When the heart calls for help: Clusterin reprograms immunity to enable regeneration

Area of Science:

• Cardiovascular Biology
• Immunology
• Regenerative Medicine

Background:

• Adult mammalian hearts have a limited capacity for regeneration after injury.
• Inflammation is a complex process following cardiac damage, with both detrimental and potentially beneficial roles.
• Understanding the mechanisms that control cardiac repair is crucial for developing new therapies.

Purpose of the Study:

• To investigate the role of neonatal cardiomyocyte-derived factors in modulating the inflammatory response post-cardiac injury.
• To elucidate the molecular mechanisms by which inflammation influences cardiomyocyte proliferation and cardiac repair.
• To identify potential therapeutic targets for enhancing heart regeneration.

Main Methods:

• Analysis of neonatal cardiomyocyte-derived factors and their interaction with immune cells.
• Investigation of Toll-like receptor 4 (TLR4) signaling pathways in macrophages.
• Assessment of bone morphogenetic protein 2 (BMP2) signaling and its effect on cardiomyocyte proliferation.
• In vivo and in vitro models of cardiac injury and repair.

Main Results:

• Neonatal cardiomyocyte-derived clusterin was identified as a key factor that suppresses inflammation.
• Clusterin competes for binding to macrophage Toll-like receptor 4 (TLR4), modulating the immune response.
• This interaction promotes a reparative polarization of macrophages.
• The cardio-immune dialogue activates BMP2 signaling, which stimulates cardiomyocyte proliferation.
• Inflammation is reframed as a cooperative driver of heart repair.

Conclusions:

• Neonatal clusterin plays a critical role in orchestrating a pro-regenerative inflammatory environment after cardiac injury.
• Targeting the interaction between clusterin, TLR4, and BMP2 signaling offers a novel therapeutic strategy for promoting cardiac regeneration.
• This study reframes the role of inflammation in heart repair, highlighting its potential as a driver of beneficial outcomes.